Blue Protocol Japanese Closed Beta Postponed Due To COVID-19 Virus

Protecting Olympic Participants from Covid-19 — The Urgent Need for a Risk-Management Approach

Detection and quantification of infectious severe acute respiratory coronavirus-2 in diverse clinical and environmental samples

Japanese rapid/living recommendations on drug management for COVID‐19: updated guidelines (September 2021) - Yamakawa - 2021 - Acute Medicine & Surgery - Wiley Online Library

SARS-CoV-2 viral load and shedding kinetics

Global Team Update - News

Blue Protocol for PC launches June 14 in Japan; delayed to 2024 in the west - Gematsu

Global Team Update - News

A Comparative Analysis of SARS-CoV-2 Antivirals Characterizes 3CLpro Inhibitor PF-00835231 as a Potential New Treatment for COVID-19

Coronavirus in Germany

Frontiers A 21st Century Evil: Immunopathology and New Therapies of COVID- 19

Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with Covid-19

Frontiers Pathophysiology and Potential Therapeutic Candidates for COVID- 19: A Poorly Understood Arena

Temporal lineage replacements and dominance of imported variants of concern during the COVID-19 pandemic in Kenya